Modeling of molecular interaction between apoptin, BCR-Abl and CrkL--an alternative approach to conventional rational drug design.
In this study we have calculated a 3D structure of apoptin and through modeling and docking approaches, we show its interaction with Bcr-Abl oncoprotein and its downstream signaling components, following which we confirm some of the newly-found interactions by biochemical methods. Bcr-Abl oncoprotei...
Main Authors: | Soumya Panigrahi, Jörg Stetefeld, Jaganmohan R Jangamreddy, Soma Mandal, Sanat K Mandal, Marek Los |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22253690/?tool=EBI |
Similar Items
-
Crk and CrkL as Therapeutic Targets for Cancer Treatment
by: Taeju Park
Published: (2021-03-01) -
The role of adaptor proteins Crk and CrkL in lens development
by: Collins, Tamica N.
Published: (2016) -
Capability of the viral NS1 proteins to bind to the cellular adaptor proteins Crk and CrkL determines sensitivity of influenza viruses to Crk/CrkL expression
by: Ehrhardt C, et al.
Published: (2009-02-01) -
Crk and CrkL adaptor proteins: networks for physiological and pathological signaling
by: Inagaki Fuyuhiko, et al.
Published: (2009-05-01) -
PF-114, a Novel Inhibitor of Bcr-Abl Chimeric Tyrosine Kinase, Attenuates Intracellular CrkL Phosphorylation and Kills Chronic Myeloid Leukemia Cells
by: ES Kolotova, et al.
Published: (2016-01-01)